These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 2410113

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Protection of T cells against infectivity and cytopathic effect of HTLV-III in vitro.
    Mitsuya H, Matsushita S, Yarchoan R, Broder S.
    Princess Takamatsu Symp; 1984; 15():277-88. PubMed ID: 6085846
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibitors of retroviral DNA polymerase: their implication in the treatment of AIDS.
    Chandra P, Vogel A, Gerber T.
    Cancer Res; 1985 Sep; 45(9 Suppl):4677s-4684s. PubMed ID: 2410112
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.
    Mitsuya H, Popovic M, Yarchoan R, Matsushita S, Gallo RC, Broder S.
    Science; 1984 Oct 12; 226(4671):172-4. PubMed ID: 6091268
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
    McDougal JS, Mawle A, Cort SP, Nicholson JK, Cross GD, Scheppler-Campbell JA, Hicks D, Sligh J.
    J Immunol; 1985 Nov 12; 135(5):3151-62. PubMed ID: 2995487
    [Abstract] [Full Text] [Related]

  • 10. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells.
    Schechter MT, Boyko WJ, Jeffries E, Willoughby B, Nitz R, Constance P, Weaver M, Wiggs B, O'Shaughnessy M.
    Can Med Assoc J; 1985 Aug 15; 133(4):286-92. PubMed ID: 2990652
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
    Essex M, McLane MF, Kanki P, Allan J, Kitchen L, Lee TH.
    Cancer Res; 1985 Sep 15; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682
    [Abstract] [Full Text] [Related]

  • 18. Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo.
    Broder S, Yarchoan R, Collins JM, Lane HC, Markham PD, Klecker RW, Redfield RR, Mitsuya H, Hoth DF, Gelmann E.
    Lancet; 1985 Sep 21; 2(8456):627-30. PubMed ID: 2863631
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone.
    Sarin PS, Sun D, Thornton A, Müller WE.
    J Natl Cancer Inst; 1987 Apr 21; 78(4):663-6. PubMed ID: 2435942
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.